130 related articles for article (PubMed ID: 34635574)
1. Interleukin 6 trans-signalling and the risk of future cardiovascular events in men and women.
Miri Y; Leander K; Eriksson P; Gigante B; Ziegler L
Open Heart; 2021 Oct; 8(2):. PubMed ID: 34635574
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 6 trans-signalling and risk of future cardiovascular events.
Ziegler L; Gajulapuri A; Frumento P; Bonomi A; Wallén H; de Faire U; Rose-John S; Gigante B
Cardiovasc Res; 2019 Jan; 115(1):213-221. PubMed ID: 30052808
[TBL] [Abstract][Full Text] [Related]
3. The predictive role of interleukin 6 trans-signalling in middle-aged men and women at low-intermediate risk of cardiovascular events.
Ziegler L; Frumento P; Wallén H; de Faire U; Gigante B
Eur J Prev Cardiol; 2020 Jan; 27(2):122-129. PubMed ID: 31438723
[TBL] [Abstract][Full Text] [Related]
4. IL6 trans-signaling associates with ischemic stroke but not with atrial fibrillation.
Ziegler L; Wallén H; Aspberg S; de Faire U; Gigante B
BMC Neurol; 2021 Aug; 21(1):306. PubMed ID: 34372806
[TBL] [Abstract][Full Text] [Related]
5. Serum IL8 is not associated with cardiovascular events but with all-cause mortality.
Moreno Velásquez I; Gajulapuri A; Leander K; Berglund A; de Faire U; Gigante B
BMC Cardiovasc Disord; 2019 Feb; 19(1):34. PubMed ID: 30717657
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular event in systemic lupus erythematosus in northern Sweden: incidence and predictors in a 7-year follow-up study.
Bengtsson C; Ohman ML; Nived O; Rantapää Dahlqvist S
Lupus; 2012 Apr; 21(4):452-9. PubMed ID: 22065097
[TBL] [Abstract][Full Text] [Related]
7. Variants in the coagulation factor 2 receptor (F2R) gene influence the risk of myocardial infarction in men through an interaction with interleukin 6 serum levels.
Gigante B; Vikström M; Meuzelaar LS; Chernogubova E; Silveira A; Hooft FV; Hamsten A; de Faire U
Thromb Haemost; 2009 May; 101(5):943-53. PubMed ID: 19404549
[TBL] [Abstract][Full Text] [Related]
8. Testosterone concentrations and risk of cardiovascular events in androgen-deficient men with atherosclerotic cardiovascular disease.
Boden WE; Miller MG; McBride R; Harvey C; Snabes MC; Schmidt J; McGovern ME; Fleg JL; Desvigne-Nickens P; Anderson T; Kashyap M; Probstfield JL
Am Heart J; 2020 Jun; 224():65-76. PubMed ID: 32335402
[TBL] [Abstract][Full Text] [Related]
9. Asymptomatic hyperuricemia is not an independent risk factor for cardiovascular events or overall mortality in the general population of the Busselton Health Study.
Nossent J; Raymond W; Divitini M; Knuiman M
BMC Cardiovasc Disord; 2016 Dec; 16(1):256. PubMed ID: 27978810
[TBL] [Abstract][Full Text] [Related]
10. High miR-133a levels in the circulation anticipates presentation of clinical events in familial hypercholesterolaemia patients.
Escate R; Padró T; Suades R; Camino S; Muñiz O; Diaz-Diaz JL; Sionis A; Mata P; Badimon L
Cardiovasc Res; 2021 Jan; 117(1):109-122. PubMed ID: 32061123
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory Markers and Outcomes in Kidney Transplant Recipients.
Molnar MZ; Nagy K; Remport A; Tapolyai MB; Fülöp T; Kamal F; Kovesdy CP; Mucsi I; Mathe Z
Transplantation; 2017 Sep; 101(9):2152-2164. PubMed ID: 27798514
[TBL] [Abstract][Full Text] [Related]
12. Maternal-placental syndrome and future risk of accelerated cardiovascular events in Parous Swedish women with systemic lupus erythematosus - a population-based retrospective cohort study with time-to-event analysis.
Soh MC; Dib F; Nelson-Piercy C; Westgren M; McCowan L; Pasupathy D
Rheumatology (Oxford); 2016 Jul; 55(7):1235-42. PubMed ID: 27016663
[TBL] [Abstract][Full Text] [Related]
13. Sex-Specific Epidemiology of Heart Failure Risk and Mortality in Europe: Results From the BiomarCaRE Consortium.
Magnussen C; Niiranen TJ; Ojeda FM; Gianfagna F; Blankenberg S; Vartiainen E; Sans S; Pasterkamp G; Hughes M; Costanzo S; Donati MB; Jousilahti P; Linneberg A; Palosaari T; de Gaetano G; Bobak M; den Ruijter HM; Jørgensen T; Söderberg S; Kuulasmaa K; Zeller T; Iacoviello L; Salomaa V; Schnabel RB;
JACC Heart Fail; 2019 Mar; 7(3):204-213. PubMed ID: 30819375
[TBL] [Abstract][Full Text] [Related]
14. Sex Differences in Cardiovascular Effectiveness of Newer Glucose-Lowering Drugs Added to Metformin in Type 2 Diabetes Mellitus.
Raparelli V; Elharram M; Moura CS; Abrahamowicz M; Bernatsky S; Behlouli H; Pilote L
J Am Heart Assoc; 2020 Jan; 9(1):e012940. PubMed ID: 31902326
[TBL] [Abstract][Full Text] [Related]
15. Circulating Branched-Chain Amino Acids and Incident Cardiovascular Disease in a Prospective Cohort of US Women.
Tobias DK; Lawler PR; Harada PH; Demler OV; Ridker PM; Manson JE; Cheng S; Mora S
Circ Genom Precis Med; 2018 Apr; 11(4):e002157. PubMed ID: 29572205
[TBL] [Abstract][Full Text] [Related]
16. Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study.
Lee JL; Sinnathurai P; Buchbinder R; Hill C; Lassere M; March L
Arthritis Res Ther; 2018 Aug; 20(1):171. PubMed ID: 30086795
[TBL] [Abstract][Full Text] [Related]
17. Insulin resistance predicts early cardiovascular morbidity in men without diabetes mellitus, with effect modification by physical activity.
Hellgren MI; Daka B; Jansson PA; Lindblad U; Larsson CA
Eur J Prev Cardiol; 2015 Jul; 22(7):940-9. PubMed ID: 24879358
[TBL] [Abstract][Full Text] [Related]
18. Soluble urokinase plasminogen activator receptor in plasma is associated with incidence of CVD. Results from the Malmö Diet and Cancer Study.
Persson M; Engström G; Björkbacka H; Hedblad B
Atherosclerosis; 2012 Feb; 220(2):502-5. PubMed ID: 22119508
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 promoter polymorphism and cardiovascular risk factors: the Health 2000 Survey.
Riikola A; Sipilä K; Kähönen M; Jula A; Nieminen MS; Moilanen L; Kesäniemi YA; Lehtimäki T; Hulkkonen J
Atherosclerosis; 2009 Dec; 207(2):466-70. PubMed ID: 19592000
[TBL] [Abstract][Full Text] [Related]
20. Nonobstructive Coronary Artery Disease at Angiography and Gender-Specific Indicators for Cardiovascular Events: 5-Year Follow-Up of the LIFE Heart Study.
Nauman AT; Teren A; Zeynalova S; Thiery J; Regitz-Zagrosek V; Scholz M; Seeland U
J Womens Health (Larchmt); 2020 Mar; 29(3):338-344. PubMed ID: 31765281
[No Abstract] [Full Text] [Related]
[Next] [New Search]
